Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Exercise / conversionCommon Stock | 32,763 | $22.77 | $746,013.51 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · nonDerivative · entry 3 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Exercise / conversionCommon Stock | 5,000 | $22.77 | $113,850.00 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · nonDerivative · entry 2 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Exercise / conversionCommon Stock | 17,731 | $9.72 | $172,345.32 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · nonDerivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 15:57 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 69 | $30.38 | $2,096.22 |
DisclosureSEC source: 0000078003-03-000218 · can456.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,120 Underlying: Common Stock · 69 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 15:57 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 50 | $30.38 | $1,519.00 |
DisclosureSEC source: 0000078003-03-000219 · cor458.xml · derivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570 Underlying: Common Stock · 50 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 15:57 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 31 | $30.38 | $941.78 |
DisclosureSEC source: 0000078003-03-000220 · har457.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,495 Underlying: Common Stock · 31 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 15:57 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 69 | $30.38 | $2,096.22 |
DisclosureSEC source: 0000078003-03-000221 · kat459.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,888 Underlying: Common Stock · 69 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 15:58 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 51 | $30.38 | $1,549.38 |
DisclosureSEC source: 0000078003-03-000222 · kin460.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,696 Underlying: Common Stock · 51 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 15:58 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 131 | $30.38 | $3,979.78 |
DisclosureSEC source: 0000078003-03-000223 · mck461.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,734 Underlying: Common Stock · 131 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 15:58 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 185 | $30.38 | $5,620.30 |
DisclosureSEC source: 0000078003-03-000224 · mit462.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,398 Underlying: Common Stock · 185 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 15:58 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 43 | $30.38 | $1,306.34 |
DisclosureSEC source: 0000078003-03-000225 · nor463.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,605 Underlying: Common Stock · 43 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 15:58 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 245 | $30.38 | $7,443.10 |
DisclosureSEC source: 0000078003-03-000226 · she464.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,021 Underlying: Common Stock · 245 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 26, 2003 Filed Sep 30, 2003 18:04 UTC |
CORNWELL W DONDirector
|
GrantPhantom Stock Units · Derivative | 397 | $30.56 | $12,132.32 |
DisclosureSEC source: 0000078003-03-000210 · cor448.xml · derivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,405 Underlying: Common Stock · 397 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 26, 2003 Filed Sep 30, 2003 18:04 UTC |
HOWELL WILLIAM RDirector
|
GrantPhantom Stock Units · Derivative | 635 | $30.56 | $19,405.60 |
DisclosureSEC source: 0000078003-03-000211 · how449.xml · derivative · entry 1 HOWELL WILLIAM R · CIK 0001174480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,541 Underlying: Common Stock · 635 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 26, 2003 Filed Sep 30, 2003 18:04 UTC |
LORCH GEORGE ADirector
|
GrantPhantom Stock Units · Derivative | 597 | $30.56 | $18,244.32 |
DisclosureSEC source: 0000078003-03-000212 · lor450.xml · derivative · entry 1 LORCH GEORGE A · CIK 0001174481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,055 Underlying: Common Stock · 597 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 26, 2003 Filed Sep 30, 2003 18:04 UTC |
MEAD DANA GDirector
|
GrantPhantom Stock Units · Derivative | 587 | $30.56 | $17,938.72 |
DisclosureSEC source: 0000078003-03-000213 · mea451.xml · derivative · entry 1 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,299 Underlying: Common Stock · 587 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 26, 2003 Filed Sep 30, 2003 18:05 UTC |
RAINES FRANKLIN DDirector
|
GrantPhantom Stock Units · Derivative | 537 | $30.56 | $16,410.72 |
DisclosureSEC source: 0000078003-03-000214 · rai452.xml · derivative · entry 1 RAINES FRANKLIN D · CIK 0001174483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,274 Underlying: Common Stock · 537 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 26, 2003 Filed Sep 30, 2003 18:05 UTC |
SIMMONS RUTH JDirector
|
GrantPhantom Stock Units · Derivative | 544 | $30.56 | $16,624.64 |
DisclosureSEC source: 0000078003-03-000215 · sim453.xml · derivative · entry 1 SIMMONS RUTH J · CIK 0001174484 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,495 Underlying: Common Stock · 544 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 26, 2003 Filed Sep 30, 2003 18:05 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Units · Derivative | 319 | $30.56 | $9,748.64 |
DisclosureSEC source: 0000078003-03-000216 · ste454.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,285 Underlying: Common Stock · 319 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 26, 2003 Filed Sep 30, 2003 18:05 UTC |
VALLES JEAN PAULDirector
|
GrantPhantom Stock Units · Derivative | 861 | $30.56 | $26,312.16 |
DisclosureSEC source: 0000078003-03-000217 · val455.xml · derivative · entry 1 VALLES JEAN PAUL · CIK 0001033869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,381 Underlying: Common Stock · 861 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 15, 2003 Filed Sep 16, 2003 15:31 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 28 | $31.86 | $892.08 |
DisclosureSEC source: 0000078003-03-000201 · har431.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,464 Underlying: Common Stock · 28 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2003 Filed Sep 16, 2003 15:31 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 62 | $31.86 | $1,975.32 |
DisclosureSEC source: 0000078003-03-000199 · can429.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,051 Underlying: Common Stock · 62 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2003 Filed Sep 16, 2003 15:31 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 48 | $31.86 | $1,529.28 |
DisclosureSEC source: 0000078003-03-000200 · cor430.xml · derivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2003 Filed Sep 16, 2003 15:31 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 49 | $31.86 | $1,561.14 |
DisclosureSEC source: 0000078003-03-000203 · kin433.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,645 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2003 Filed Sep 16, 2003 15:31 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 56 | $31.86 | $1,784.16 |
DisclosureSEC source: 0000078003-03-000202 · kat432.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,819 Underlying: Common Stock · 56 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2003 Filed Sep 16, 2003 15:31 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 146 | $31.86 | $4,651.56 |
DisclosureSEC source: 0000078003-03-000205 · mit435.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,213 Underlying: Common Stock · 146 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2003 Filed Sep 16, 2003 15:31 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 102 | $31.86 | $3,249.72 |
DisclosureSEC source: 0000078003-03-000204 · mck434.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,603 Underlying: Common Stock · 102 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2003 Filed Sep 16, 2003 15:31 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 27 | $31.86 | $860.22 |
DisclosureSEC source: 0000078003-03-000206 · nor436.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,562 Underlying: Common Stock · 27 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2003 Filed Sep 16, 2003 15:31 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 217 | $31.86 | $6,913.62 |
DisclosureSEC source: 0000078003-03-000207 · she437.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,776 Underlying: Common Stock · 217 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 29, 2003 Filed Sep 2, 2003 19:14 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 72 | $29.92 | $2,154.24 |
DisclosureSEC source: 0000078003-03-000184 · can420.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,989 Underlying: Common Stock · 72 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 29, 2003 Filed Sep 2, 2003 19:17 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 50 | $29.92 | $1,496.00 |
DisclosureSEC source: 0000078003-03-000185 · cor421.xml · derivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472 Underlying: Common Stock · 50 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 29, 2003 Filed Sep 2, 2003 19:18 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 79 | $29.92 | $2,363.68 |
DisclosureSEC source: 0000078003-03-000186 · kat428.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,763 Underlying: Common Stock · 79 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 29, 2003 Filed Sep 2, 2003 19:19 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 52 | $29.92 | $1,555.84 |
DisclosureSEC source: 0000078003-03-000187 · kin423.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,596 Underlying: Common Stock · 52 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 29, 2003 Filed Sep 2, 2003 19:23 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 152 | $29.92 | $4,547.84 |
DisclosureSEC source: 0000078003-03-000188 · mck424.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,501 Underlying: Common Stock · 152 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 29, 2003 Filed Sep 2, 2003 19:23 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 208 | $29.92 | $6,223.36 |
DisclosureSEC source: 0000078003-03-000189 · mit425.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,067 Underlying: Common Stock · 208 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 29, 2003 Filed Sep 2, 2003 19:24 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 54 | $29.92 | $1,615.68 |
DisclosureSEC source: 0000078003-03-000190 · nor426.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,535 Underlying: Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 29, 2003 Filed Sep 2, 2003 19:24 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 261 | $29.92 | $7,809.12 |
DisclosureSEC source: 0000078003-03-000191 · she427.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,559 Underlying: Common Stock · 261 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 29, 2003 Filed Sep 2, 2003 19:25 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 32 | $29.92 | $957.44 |
DisclosureSEC source: 0000078003-03-000192 · har422.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,436 Underlying: Common Stock · 32 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 27, 2003 Filed Aug 28, 2003 13:06 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,600 | $0.00 Strike: $5.71 | $0.00 |
DisclosureSEC source: 0000078003-03-000183 · can419.xml · derivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,100 Underlying: Common Stock · 3,600 shares Expires 2004-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in 3 equal annual installments beginning on August 25,1995. Read SEC document |
| August 27, 2003 Filed Aug 28, 2003 13:06 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
Tax withholdingCommon Stock | 682 | $30.17 | $20,575.94 |
DisclosureSEC source: 0000078003-03-000183 · can419.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,986 Read SEC document |
| August 27, 2003 Filed Aug 28, 2003 13:06 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
Exercise / conversionCommon Stock | 3,600 | $5.71 | $20,556.00 |
DisclosureSEC source: 0000078003-03-000183 · can419.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2003 Filed Mar 3, 2004 16:10 UTC |
HARDWICK CHARLES LSenior Vice President
|
SaleCommon Stock | 61 | $30.91 | $1,885.51 |
DisclosureSEC source: 0000078003-04-000045 · har587.xml · nonDerivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,736 F1 · security: This sale was effected by Mr. Hardwick's portfolio manager without his prior knowledge and contrary to written instructions to the portfolio manager not to trade in Pfizer securities on Mr. Hardwick's behalf. Read SEC document |
| August 15, 2003 Filed Aug 18, 2003 19:20 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 90 | $31.42 | $2,827.80 |
DisclosureSEC source: 0000078003-03-000173 · can409.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,917 Underlying: Common Stock · 90 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 15, 2003 Filed Aug 18, 2003 19:20 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 50 | $31.42 | $1,571.00 |
DisclosureSEC source: 0000078003-03-000174 · cor410.xml · derivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422 Underlying: Common Stock · 50 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 15, 2003 Filed Aug 18, 2003 19:20 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 46 | $31.42 | $1,445.32 |
DisclosureSEC source: 0000078003-03-000175 · har411.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,404 Underlying: Common Stock · 46 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 15, 2003 Filed Aug 18, 2003 19:20 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 190 | $31.42 | $5,969.80 |
DisclosureSEC source: 0000078003-03-000176 · kat412.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,684 Underlying: Common Stock · 190 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 15, 2003 Filed Aug 18, 2003 19:25 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 57 | $31.42 | $1,790.94 |
DisclosureSEC source: 0000078003-03-000177 · kin413.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,544 Underlying: Common Stock · 57 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 15, 2003 Filed Aug 18, 2003 19:25 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 423 | $31.42 | $13,290.66 |
DisclosureSEC source: 0000078003-03-000178 · mck414.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,349 Underlying: Common Stock · 423 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 15, 2003 Filed Aug 18, 2003 19:25 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 421 | $31.42 | $13,227.82 |
DisclosureSEC source: 0000078003-03-000179 · mit415.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,859 Underlying: Common Stock · 421 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 15, 2003 Filed Aug 18, 2003 19:25 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 163 | $31.42 | $5,121.46 |
DisclosureSEC source: 0000078003-03-000180 · nor416.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,481 Underlying: Common Stock · 163 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.